Rezvan Ameli

Clinical Psychologist at the National Institutes of Health (NIH)

Papers

5 publications

Trials

0 clinical trials

Links

Key Impact

She has contributed to foundational NIH-HEALS and psychedelic-assisted therapy research in cancer patients, helping measure and characterize psycho-social-spiritual change and suicidal ideation outcomes in rapid-acting antidepressant studies.

Background & Research

Rezvan Ameli, PhD, is a clinical psychologist and mindfulness instructor at the NIH Clinical Center, where she has worked as a clinician, researcher, writer, and teacher for more than 20 years. Her earlier work focused on mindfulness, stress reduction, and psychological well-being, and she has held academic positions at Yale University, the University of Connecticut, and Howard University. More recently, she has coauthored studies on ketamine and psilocybin-assisted therapy in depression, bipolar depression, and cancer-related distress.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

12 collaborators· click a node to visit their profile

Full network →